Home > PE Ratio > CORAL LABORATORIES

CORAL LABORATORIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of CORAL LABORATORIES is 8.71.

Share Price ₹655.8May 07,2025
Market Cap ₹236.1 Cr
Earnings-TTM₹27.1 CrTTM-Standalone Results
Price/Earnings8.71xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for CORAL LABORATORIES
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of CORAL LABORATORIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of CORAL LABORATORIES is calculated as :

Current Market Cap [ ₹236.1 Cr] as on May 07,2025

(/) Earnings [ ₹27.1 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 8.71x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for CORAL LABORATORIES , the investors are currently willing to pay 8.71 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of CORAL LABORATORIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of CORAL LABORATORIES over the last five years.

Historical PE (Price/Earnings) ratio chart of CORAL LABORATORIES


PE Ratio Performance Analysis for CORAL LABORATORIES

- CORAL LABORATORIES 's latest p/e ratio is 8.71x.

- CORAL LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 8.91x.

- CORAL LABORATORIES 's operated at median p/e ratio of 8.49x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, CORAL LABORATORIES 's p/e ratio peaked in Mar2023 at 12.69x.

- CORAL LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 4.91x.


How does CORAL LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
CORAL LABORATORIES 27.128.71236.1
SUN PHARMACEUTICAL INDUSTRIES LTD11,486.0037.21427,406.0
DIVIS LABORATORIES LTD2,067.0078.91163,113.0
CIPLA LTD5,000.4324.37121,869.0
TORRENT PHARMACEUTICALS LTD1,862.0059.80111,345.0
DR REDDYS LABORATORIES LTD5,428.6017.8396,801.0
MANKIND PHARMA LTD2,050.7348.89100,259.0
ZYDUS LIFESCIENCES LTD4,591.8019.4389,232.8
LUPIN LTD2,892.1032.7094,563.0
AUROBINDO PHARMA LTD3,500.2519.8669,524.9
ABBOTT INDIA LTD1,334.4648.1864,299.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs CORAL LABORATORIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 8.71x
Max industry PE 78.91x
Median industry PE 32.70x
Average industry PE 35.99x



You may also like the below Video Courses